SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	4.78	0.8	1.31	1.8	4.61
Cash & Short-Term Investments	4.78	0.8	1.31	1.8	4.61
Cash Growth	496.75%	-38.95%	-27.32%	-60.85%	113.51%
Accounts Receivable	1.53	0.28	0	0	-
Other Receivables	-	0.06	0.3	0.33	0.21
Receivables	1.53	0.34	0.3	0.33	0.21
Inventory	0.8	0.47	0.03	0.12	-
Prepaid Expenses	-	0.06	0.07	0.08	0.24
Total Current Assets	7.11	1.67	1.72	2.33	5.06
Property, Plant & Equipment	0.73	0.12	0.17	0.13	0.14
Goodwill	2.42	2.04	-	-	-
Other Intangible Assets	1.87	1.39	0.7	0.63	0.53
Total Assets	12.13	5.22	2.59	3.08	5.73
Accounts Payable	1.07	0.28	0.19	0.07	0.08
Accrued Expenses	-	0.21	0.3	0.37	0.28
Short-Term Debt	-	0.74	-	-	-
Current Portion of Leases	0.11	0.04	0.03	0.03	0.03
Current Income Taxes Payable	0.03	0.03	-	0.03	0.02
Other Current Liabilities	0.25	0.5	0	0.01	0
Total Current Liabilities	1.47	1.8	0.53	0.51	0.4
Long-Term Debt	0.6	-	-	-	-
Long-Term Leases	0.28	0.04	0.07	0.1	0.11
Long-Term Deferred Tax Liabilities	0.36	0.15	-	-	-
Other Long-Term Liabilities	-	0.25	-	-	-
Total Liabilities	2.71	2.25	0.6	0.61	0.52
Common Stock	2.59	2.02	1.73	1.57	1.57
Additional Paid-In Capital	21.09	14.51	10.95	8.76	8.76
Retained Earnings	-14.7	-14	-11.12	-8.29	-5.5
Comprehensive Income & Other	0.44	0.44	0.44	0.44	0.38
Shareholders' Equity	9.42	2.97	1.99	2.48	5.22
Total Liabilities & Equity	12.13	5.22	2.59	3.08	5.73
Total Debt	0.99	0.82	0.1	0.13	0.14
Net Cash (Debt)	3.79	-0.02	1.21	1.68	4.47
Net Cash Growth	-	-	-27.78%	-62.48%	107.04%
Net Cash Per Share	0.02	-0.00	0.01	0.01	0.03
Filing Date Shares Outstanding	226.18	202.26	173.14	156.78	156.78
Total Common Shares Outstanding	226.18	202.26	173.14	156.78	156.78
Working Capital	5.64	-0.13	1.19	1.82	4.66
Book Value Per Share	0.04	0.01	0.01	0.02	0.03
Tangible Book Value	5.13	-0.46	1.29	1.85	4.69
Tangible Book Value Per Share	0.02	-0.00	0.01	0.01	0.03

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.